Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision badge updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 was added replacing v3.3.3; this is a minor metadata update that does not affect the study content or presentation; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange Detected- The page now includes new Location sections and site entries (California, New York, Rio de Janeiro, Alberta, Ontario, Quebec, Lazio, Liguria, Lombardy, Moscow Oblast, Barcelona) and removes several regional location blocks. Revision identifiers updated (v3.3.2 to v3.3.3).SummaryDifference0.8%

- Check91 days agoChange DetectedAdded note that publications are automatically filled from PubMed and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRemoved an operational government funding notice; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.